Treatment of benign prostatic hyperplasia by natural drugs

E Csikós, A Horváth, K Ács, N Papp, VL Balázs… - Molecules, 2021 - mdpi.com
Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting
men, generally after the age of 50. The prevalence of this multifactorial disease increases …

The steroidal alkaloids α-tomatine and tomatidine: Panorama of their mode of action and pharmacological properties

C Bailly - Steroids, 2021 - Elsevier
The steroidal glycoalkaloid α-tomatine (αTM) and its aglycone tomatidine (TD) are abundant
in the skin of unripe green tomato and present in tomato leaves and flowers. They mainly …

Unraveling the ethnopharmacological potential of medicinal plants used in Algerian traditional medicine for urinary diseases

K Taibi, LA Abderrahim, M Boussaid, F Taibi… - European Journal of …, 2021 - Elsevier
Introduction Traditional medicine is gaining increasing importance worldwide for the
management of various health conditions, including urinary diseases. Little is known about …

The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: a new perspective

TJ Phua - Medicines, 2021 - mdpi.com
Background: The etiology of benign prostatic hyperplasia and prostate cancer are unknown,
with ageing being the greatness risk factor. Methods: This new perspective evaluates the …

Pharmacological effects and potential clinical usefulness of polyphenols in benign prostatic hyperplasia

K Mitsunari, Y Miyata, T Matsuo, Y Mukae, A Otsubo… - Molecules, 2021 - mdpi.com
Benign prostatic hyperplasia (BPH) is arguably the most common benign disease among
men. This disease is often associated with lower urinary tract symptoms (LUTS) in men and …

Astaxantin and isoflavones inhibit benign prostatic hyperplasia in rats by reducing oxidative stress and normalizing Ca/Mg Balance

AL Semenov, EA Gubareva, ED Ermakova… - Plants, 2021 - mdpi.com
Benign prostatic hyperplasia (BPH) is a common pathology among aging men. Despite the
broad pharmacological interventions, the available remedies to treat BPH are yet not devoid …

[HTML][HTML] Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and …

H Almukadi, BG Eid, RA Shaik, AB Abdel-Naim… - Biomedicine & …, 2021 - Elsevier
Benign prostatic hyperplasia (BPH) is a disease that commonly strikes the majority of aged
men. Developing new therapies to manage BPH with improved efficacy and safety is …

Herbal nutraceutical treatment of chronic prostatitis–chronic pelvic pain syndrome: a literature review

O Dashdondov, J Wazir, G Sukhbaatar… - … Urology and Nephrology, 2021 - Springer
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the most frequent form of
prostatitis, and has a serious impact on patients' quality of life, and causes severe symptoms …

Suppressive Effect and Molecular Mechanism of Houttuynia cordata Thunb. Extract against Prostate Carcinogenesis and Castration-Resistant Prostate Cancer

S Subhawa, A Naiki-Ito, H Kato, T Naiki, M Komura… - Cancers, 2021 - mdpi.com
Simple Summary This study explored the chemopreventive effects of Houttuynia cordata
Thunb.(HCT) extracts against prostate carcinogenesis in both androgen-sensitive prostate …

Pumpkin seed extracts inhibit proliferation and induce autophagy in PC-3 androgen insensitive prostate cancer cells

T Nomikos, K Gioti, M Tsoukala… - Journal of Medicinal Food, 2021 - liebertpub.com
Pumpkin seed is a rich source of polyphenols and other bioactive compounds that may act
as chemopreventive agents against cancer. In this study, five different extracts of pumpkin …